Daniel Ives presents to the Foresight Biotech & Health extension

Daniel Ives presents to the Foresight Biotech & Health extension

You may be interested in

Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics

Read more

Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics

Read more